Axonics
USAxonics is a healthcare company, headquartered in United States.
Entry
2014
Hold
10yr
Exit
2024
Est. EV
–
Who owns Axonics?
Axonics was owned by Edmond de Rothschild Private Equity (France) through Edmond de Rothschild Investment Partners BioDiscovery 4 (2015 vintage) from 2014 to 2024, exited via Trade Sale. Across its history, Axonics has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Edmond de Rothschild Private Equity (France)Edmond de Rothschild Investment Partners BioDiscovery 4 · 2015 · VC
2 ownership periods · full history below
Key facts
HQUnited States
SectorHealthcare
Key takeaways
- ·Fully exited in 2024.
- ·Average hold across 2 realized cycles: 8 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2024 to .
Co-invest · 2 holders · 2014 · 2024
Edmond de Rothschild Private Equity (France)Exited 2024
2014 · 2024 · Edmond de Rothschild Investment Partners BioDiscovery 4 · 2015 · VC
Trade Sale · to
MOIC
–
More from Edmond de Rothschild Investment Partners BioDiscovery 4
Other portfolio companies in the same fund.
Finland
FranceMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Data refreshed weekly · Sourced from public filings